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Introduction
Minimally invasive laparoscopic surgery continues to be the 
leading surgical method, offering a shorter recovery time, 
less postoperative pain, better cosmetic outcomes, and lower 
complication rates compared to open abdominal surgery [1-
3]. Unfortunately, some difficulty remains in removing large-
sized specimens via single-port assisted (SPA) laparoscopy. A 
considerable amount of time and effort must be invested for 
morcellation, which is the fragmentation of a tissue specimen 
to reduce it to a compact size, enabling extraction through 
smaller incisions [4].
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Objective 
This study introduces and evaluates the feasibility, safety, and surgical outcomes of the in-bag power morcellation 
technique during single-port assisted (SPA) laparoscopic myomectomy in comparison with manual scalpel 
morcellation.
Methods
This is a retrospective review of a total of 58 patients who underwent SPA laparoscopic myomectomy employing 
in-bag power morcellation (n=27) or manual scalpel morcellation (n=31), performed between December 2014 and 
December 2016. Surgical outcomes, including total operation time, estimated blood loss, postoperative hemoglobin 
changes, postoperative hospital stay, postoperative pain (visual analog scale), perioperative and postoperative 
complications were evaluated.
Results
The demographics and patient characteristics were similar between both groups. The median patient age was 34 
years and median body mass index was 20.84 kg/m2. The median specimen weight was 110 g. The median operating 
time was 138 minutes. The median estimated blood loss was 50 mL and the median postoperative hemoglobin change 
was 2.2 g/dL. The median postoperative hospital stay was 2 days and the median postoperative pain scores were 5 
after 6 hours, 3 after 24 hours, and 2 after 48 hours. Occult malignancy was not identified in any patients. There were 
no intraoperative complications such as LapBag ruptures or gross spillage. 
Conclusion
In-bag power morcellation for SPA laparoscopic myomectomy is feasible and safe, minimizing the risks of open power 
morcellation. There were also no statistically significant differences in surgical outcomes.
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The prototype for power morcellation was first introduced 
in 1993 by Rolf Steiner of Switzerland [5]. Electromechanical 
morcellation is an easy and efficient method for removing 
tissue from the abdominal cavity compared to hand-manip-
ulated morcellation [6]. However, power morcellation related 
complications such as injury from morcellator blades to vessels 
or adjacent visceral organs is a concern [7].
This method also introduces the risk of unintentional dis-
semination of removed tissue, which could lead to benign 
myoma seeding or spillage of malignant material into the 
peritoneal cavity if that tissue is pathologically confirmed to be 
endometrial cancer or sarcoma [8,9]. A safety communication 
warning published by the U.S. Food and Drug Administration 
in April 2014 advised against the use of power morcellation 
due to the risk of intra-abdominal malignancy dissemination 
during laparoscopy [10].
The purpose of this study is to introduce and evaluate the 
feasibility, safety, and surgical outcomes of the in-bag power 
morcellation technique during SPA laparoscopic myomectomy 
in comparison with manual scalpel morcellation. 
Materials and methods
This study is a retrospective review of a total of 58 patients 
who underwent SPA laparoscopic myomectomy employing 
in-bag power morcellation (n=27) or manual scalpel morcel-
lation (n=31), performed between December 2014 and De-
cember 2016 at Severance Hospital, Yonsei University College 
of Medicine, in Seoul, Korea. All surgeries were performed 
by a single gynecologic surgeon specializing in minimally in-
vasive gynecologic surgical techniques. We received written 
consent from all patients prior to surgery. Inclusion criteria for 
this study limited subjects to women undergoing laparoscopic 
surgical treatment for a benign disease of the uterus such as 
myoma, adenomyosis, and/or adenomyoma. Exclusion crite-
ria included patients with known or suspected malignancies. 
Pathologic confirmation was done using tissue extracted dur-
ing surgery. Patients were categorized into 2 groups according 
to whether they received specimen extraction using in-bag 
power morcellation or manual morcellation using a scalpel.
Demographic and physical characteristics such as age, coital 
history, parity, body mass index (BMI), previous surgical his-
tory, and surgical indication were investigated. Parity included 
both vaginal and cesarean section delivery. Preoperative evalu-
ation included cervical cytology and imaging evaluation such 
as ultrasonography, magnetic resonance imaging, or abdomi-
nal and pelvic computed tomography scans. Myoma size and 
location were ascertained by imaging. Surgical outcomes such 
as estimated blood loss during surgery (mL), serum hemo-
globin (Hb) differences (the change between pre-surgical Hb 
and postoperative day 1 Hb), total operation time (minutes), 
postoperative hospital stay (days), and the dry weight of the 
extracted specimen (g) were also investigated. Total operation 
time was calculated as the time from initial incision to final 
closure. Estimated blood loss during surgery was approxi-
mated as the total suctioned volume. Hospital discharge was 
determined according to whether patients were afebrile for 
24 hours, could tolerate a soft diet, could ambulate without 
assistance, and were able to urinate independently after uri-
nary catheter removal. Postoperative pain was appraised ac-
cording to the visual analog scale. Patients were asked to rate 
postoperative pain 6, 24, and 48 hours following surgery.
1. Surgical techniques
All SPA laparoscopic surgeries were performed according to 
a technique previously described by our group [11]. The SPA 
system entails a single multichannel port at the umbilicus. In-
bag power morcellation was performed by morcellating the 
removed uterine tissue inside an insufflated endoscopic bag 
within the abdominal cavity (Supplementary Video 1).
With this single-port surgery technique, an Alexis wound re-
tractor (Applied Medical, Rancho Santa Margarita, CA, USA) 
was inserted into the abdomen through a 2 cm trans-umbil-
ical incision site. A 7½ left-handed surgical glove was affixed 
to the wound retractor. Incisions were made in the glove fin-
gertips. A 12-mm trocar was inserted into the thumb, a 5-mm 
trocar into the pinky, and a 5-mm mini trocar into the middle 
finger. A 45-cm rigid, 30 degrees 5-mm endoscope was used. 
Instruments used during surgery included a monopolar L-
hook, atraumatic graspers, scissors, biopsy forceps with a 
slightly-bent shaft, a suction-irrigation system, laparoscopic 
needle holders, and energy devices such as Enseal (Ethicon, 
Somerville, NJ, USA) and Thunderbeat (Olympus Medical Sys-
tems, Tokyo, Japan) [11].
Standard procedure was used for myomectomy. A monopo-
lar hook was used to make a vertical incision in the prominent 
part of the myoma. Dissection of the cleavage plane between 
the myoma and surrounding tissue was then completed. 
Enucleation and removal were achieved by fixing and imple-
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menting traction on the myoma. Thunderbeat was used for 
dissection in several cases. The myomectomy site was repaired 
in 2 layers with an intracorporeal continuous suture and tie. 
For in-bag power morcellation, a 30 cm2 laparoscopic speci-
men retrieval bag, XXL or 3XL LapBag (Sejong Medical Co., 
Seoul, Korea), was used to remove the myoma without spill-
age. After inserting the LapBag into the abdominal cavity, 
it was opened intra-abdominally and the myoma specimen 
was placed into the LapBag and pulled out midway through 
the wound retractor by drawing on the thread of the bag. 
The surgical glove was then detached from the Alexis wound 
retractor. The wound retractor and surgical glove were reat-
tached together by folding 3 or 4 times with the LapBag 
inserted in between (Fig. 1, Supplementary Video 2). After 
completely attaching the LapBag to the wound retractor and 
surgical glove, CO2 gas was pumped into the bag. The 12-
mm trocar was separated from the surgical glove, and the 
power morcellator (Chungang Medical Co., Seoul, Korea) was 
inserted into the thumb of the surgical glove. The entire my-
oma was morcellated while contained within the insufflated 
bag (Fig. 2, Supplementary Video 3). After morcellation was 
complete, the surgeon examined the bag for tears and in-
spected the pelvis for visible spillage of fluid or uterine tissue. 
Fig. 1. Simulation of 3XL LapBag insufflated with CO2 gas at-
tached to single-port wound retractor.
Fig. 2. Intraoperative laparoscopic view of myoma power morcellation while contained within insufflated LapBag. (A) 3XL LapBag is 
opened intra-abdominally. (B) Myoma is inserted into the LapBag. (C) The myoma is grabbed with morcellator instrument. (D) The myoma 
is power morcellated within the insufflated LapBag.
A  B
C  D
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In patients with small myomas that can be easily removed 
through the umbilical incision, manual morcellation technique 
was usually selected. But in patients with relatively large myo-
mas (>5 cm), power morcellation was predominantly selected 
except when the power morcellator was not available.
2. Statistical analysis
The demographic and physical characteristics of all patients 
were obtained retrospectively. Surgical outcome results were 
obtained pre- and post-operatively. All statistical analyses were 
performed using SPSS ver. 23 (SPSS Inc., Chicago, IL, USA). 
Descriptive statistics were used to summarize the results of 
the patients’ characteristics and operation outcomes. All data 
was analyzed using the Student’s t-test or Pearson’s χ2 test 
and reported as a value of number (%) or a median (range). 
Results
The in-bag morcellation technique for specimen extraction 
was successfully performed in all 27 cases. The demographic 
and physical characteristics of the patients are shown in Table 1. 
A known huge myoma (n=12, 44.4%) was the leading in-
dicator for surgery. Other indications included hypermenor-
rhea (n=5, 18.5%), an increase in myoma size (n=5, 18.5%), 
and pelvic pain (n=5, 18.5%). Four (14.8%) and 9 (29.0%) 
women had received previous abdominal surgeries in the in-
bag morcellation group and the manual scalpel morcellation 
group, respectively. The median patient age was 34 years 
(range, 26–54), and the median BMI was 20.84 kg/m2 (range, 
18.26–28.89) for the in-bag morcellation group. For the man-
ual morcellation group, the median patient age was 37 years 
(range, 26–59) and the median BMI was 21.93 kg/m2 (range, 
19.07–29.41). There were no significant differences in age, 
parity, coital history, or BMI (Table 1) between the 2 groups.
The surgical outcomes of the patients are shown in Table 2. 
The sizes of the largest uterine tissue removed differed from 
4 to 10 cm vs. 3 to 9 cm, and the median specimen weight 
was 110 g (range, 40–413) vs. 88 g (range, 9–258). The me-
dian operating time was 138 minutes (range, 60–308) vs. 129 
minutes (range, 51–270). The average time taken to prepare 
a device for in-bag power morcellation was approximately 5 
to 10 minutes. No surgical procedures were converted from 
laparoscopy to laparotomy. Estimated blood loss was 50 mL 
(range, minimal–200) vs. 30 mL (range, minimal–180), and 
the median postoperative Hb change was 2.2 g/dL (range, 
0.5–3.8) vs. 1.7 g/dL (range, 0–3.3). Severe adhesions requir-
ing adhesiolysis during surgery were seen in 7 women (25.9%) 
in the in-bag morcellation group and 9 women (29.0%) in 
the manual morcellation group. The mean postoperative 
hospital stay was 2 days (range, 0–5) vs. 2 days (range, 1–4), 
and the median postoperative pain scores were 5 (range, 2–7) 
after 6 hours, 3 (range, 1–5) after 24 hours, and 2 (range, 1–5) 
after 48 hours vs. 5 (range, 1–10) after 6 hours, 3 (range, 2–7) 
after 24 hours, and 2 (range, 0–5) after 48 hours. There were 
no significant differences in surgical outcomes such as total 
dry specimen weight, total operating time, estimated blood 
loss, Hb difference, postoperative hospital stays, or postopera-
tive pain scores (Table 2).
Pathologic confirmation following the surgical removal of 
Table 1. Demographics and physical characteristics
Characteristics In-bag power morcellation Manual scalpel morcellation P-value
Age (yr) 34 (26–54) 37 (26–59) 0.372a)
BMI (kg/m2) 20.84 (18.26–28.89) 21.93 (19.07–29.41) 0.067a)
Parity 9.0 (33.3) 10.7 (35.5) 0.864b)
Previous abdominal surgery history 4 (14.8) 9 (29.0) 0.195b)
Indication for surgery 0.635b)
   Known huge myoma 12 (44.4) 12 (38.7)
   Hypermenorrhea 5 (18.5) 7 (22.6)
   Myoma size increase 5 (18.5) 9 (29.0)
   Pelvic pain 5 (18.5) 3 (9.7)
Values are presented as median (range) or number (%).
BMI, body mass index.
a)Student's t-test; b)Pearson's χ2 test.
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Table 2. Surgical outcomes
Outcomes In-bag power morcellation Manual scalpel morcellation P-value
Operation time (min) 138 (60–308) 129 (51–270) 0.553a)
Estimated blood loss (mL) 50 (0–200) 30 (0–180) 0.059a)
Hb change (g/dL) 2.2 (0.5–3.8) 1.7 (0–3.3) 0.098a)
Postoperative hospital stays (day) 2 (0–5) 2 (1–4) 0.395a)
Pain score (VAS)
   6 hr after operation 5 (2–7) 5 (1–10) 0.908a)
   24 hr after operation 3 (1–5) 3 (2–7) 0.347a)
   48 hr after operation 2 (1–5) 2 (0–5) 0.590a)
Specimen dry weight (g) 110 (40–413) 88 (9–258) 0.061a)
Surgical complication 0 0
Pelvic adhesion requiring adhesiolysis 7 (25.9) 9 (29.0) 0.792b)
Pathology 0.383b)
   Leiomyoma 23 (85.2) 27 (87.1)
   Leiomyoma with degeneration 1 (3.7) 3 (9.7)
   Lipoleiomyoma 1 (3.7) 1 (3.2)
   Adenomyoma 2 (7.4) 0 (0)
Values are presented as median (range) or number (%).
Hb, hemoglobin; VAS, visual analog scale.
a)Student's t-test; b)Pearson's χ2 test.
tissue showed that all patients had benign diseases of the 
uterus (Table 2). Occult malignancy was not identified in any 
patients. There were no intraoperative complications such as 
LapBag ruptures or gross spillage upon visual inspection fol-
lowing surgery. There was also no evidence of tissue dissemi-
nation outside of the bag.
Discussion
A major concern with power morcellation is the dissemination 
of removed tissue into the surrounding area [12]. The dis-
persal of benign pathology such as leiomyomas can result in 
recurrences [13]. Even more alarming is the risk of malignancy 
dispersal, as with endometrial cancer, which can result in a 
decrease in the overall survival rate [14]. Several methods of 
specimen removal have been reported to reduce this risk such 
as vaginal culdotomy or colpotomy extraction, hysteroscopic 
removal of submucosal myomas, and laparotomy [15]. Of par-
ticular interest is contained power morcellation, which allows 
the surgeon to utilize an electromechanical morcellator while 
eliminating the associated risks [16]. Several gynecological 
oncologists have delineated methods of in-bag morcellation 
that provide safe and feasible outcomes [17-20]. Our study 
describes an in-bag morcellation technique that is easily ap-
plicable for SPA laparoscopic myomectomy at our institution.
The demographics and patient characteristics of the sub-
jects considered were similar between the in-bag power mor-
cellation group and the manual scalpel morcellation group. 
Furthermore, there were no statistically significant differences 
in surgical outcomes between the 2 groups. A history of 
previous abdominal surgeries can lead to pelvic adhesions 
that consequently result in a more complicated and lengthy 
surgery. Patients with pelvic adhesions significant enough to 
require adhesiolysis during surgery were similar in number for 
both groups.
The surgical outcomes were also similar between the in-bag 
power morcellation group and the manual scalpel morcella-
tion group. Although we had anticipated the surgery duration 
to be shorter with power morcellation, operation time was 
approximately 2 hours for both groups. This could be ex-
plained by the fact that total operation time included the time 
needed to assemble the apparatus needed for in-bag morcel-
lation. Further prospective studies should include a calculation 
of exact morcellation time, excluding the time needed for 
preparation. Also, the patients undergoing each method were 
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not randomized. Surgeon bias as to which patient should 
receive power morcellation and which patient should receive 
scalpel morcellation can be expected. Larger myomas, which 
may take longer to morcellate, are likely to have been chosen 
for in-bag power morcellation, while smaller myomas under-
went manual scalpel morcellation. Although not statistically 
significant, this difference is reflected in the higher specimen 
dry weight found for in-bag morcellation cases (110 g) com-
pared to manual scalpel morcellation cases (88 g). Similarities 
in estimated blood loss, Hb change, postoperative hospital 
stay, and pain scores demonstrated the non-inferiority of in-
bag power morcellation. There were no surgical complica-
tions, such as wound complications, fistulas, adjacent organ 
injuries, or recurrences, for either group. Our in-bag power 
morcellation method had not been actively utilized until re-
cently, so long-term follow-up of patients was not possible. 
Complications such as recurrences may be discovered if a 
long-term follow-up is done.
The strength of our study was the fact that all data retrieved 
was from a single medical facility and all surgical procedures 
were performed by a single, experienced gynecologic surgeon 
with the same protocol. This reduced variations in technique. 
Inter-observer bias was also prevented. A limitation of this 
study was its small population pool and homogenous patient 
demographics. Additional randomized trials involving a larger 
population should be carried out to fully corroborate the data 
found in this study and evaluate the potential benefits of this 
surgical technique. All results were coalesced retrospectively, 
allowing the possibility of selection bias. We were not able 
to determine if any microspillage occurred during the surgery 
because we did not test the LapBag for microperforations. 
Only visual examinations for gross spillage were done. Further 
analysis utilizing dyes postoperatively to identify any micrope-
rforations could be conducted to provide a more exhaustive 
database.
A special report was released by the American Congress of 
Obstetricians and Gynecologists stating that power morcella-
tion should be permitted for women who would benefit from 
it, but appropriate patient selection and informed consent are 
necessary [21]. A statement from the American Association of 
Gynecologic Laparoscopists also asserted that converting all 
surgical procedures to open surgeries instead of using power 
morcellation would result in higher mortality rates from sur-
gery [22]. Undoubtedly, power morcellation has its benefits, 
and appropriate use should be considered suitable as long as 
patients are properly informed of the risks. The U.S. Food and 
Drug Administration even released a statement allowing a tis-
sue containment system to be marketed [23].
In conclusion, in-bag power morcellation for SPA laparo-
scopic myomectomy is feasible and safe, minimizing the risks 
of open power morcellation. 
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Supplementary Video 1. Myoma power morcellation in 3XL 
LapBag. 
Supplementary Video 2. Attaching 3XL LapBag.
Supplementary Video 3. Laparoscopic intra-abominal view of 
In-bag power morcellation. 
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